Cost-effectiveness of a new autoantibody test added to Computed Tomography (CT) compared to CT surveillance alone in the diagnosis of lung cancer amongst patients with indeterminate pulmonary nodules.

Sutton, Andrew John; Sagoo, Gurdeep S; Jackson, Leon; Fisher, Mike; Hamilton-Fairley, Geoffrey; Murray, Andrea; Hill, Adam

Sutton, Andrew John; Sagoo, Gurdeep S; Jackson, Leon; Fisher, Mike; Hamilton-Fairley, Geoffrey; Murray, Andrea; Hill, Adam.

Affiliation

Sutton AJ; Institute of Health Economics, Edmonton, Alberta, Canada.
Sagoo GS; Test Evaluation Group, Institute of Health Sciences, University of Leeds, Leeds, United Kingdom.
Jackson L; Oncimmune Limited, City Hospital, Clinical Sciences Building, Nottingham, United Kingdom.
Fisher M; Oncimmune Limited, City Hospital, Clinical Sciences Building, Nottingham, United Kingdom.
Hamilton-Fairley G; Oncimmune Limited, City Hospital, Clinical Sciences Building, Nottingham, United Kingdom.
Murray A; Oncimmune Limited, City Hospital, Clinical Sciences Building, Nottingham, United Kingdom.
Hill A; Oncimmune Limited, City Hospital, Clinical Sciences Building, Nottingham, United Kingdom.

PLoS One ; 15(9): e0237492, 2020.

Article in En | MEDLINE | ID: mdl-32877432

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Tomography, X-Ray Computed / Cost-Benefit Analysis / Multiple Pulmonary Nodules / Lung Neoplasms Type of study: Diagnostic_studies / Guideline / Health_economic_evaluation / Prognostic_studies / Screening_studies Aspects: Patient_preference Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2020 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google